Published 3 years ago

Rep. Zeldin was treated for leukemia and is now in remission

Summary by Associated Press News

0 Articles

All

Left

Center

Right

Times of India

Rep. Zeldin, who's running for New York governor, treated for leukemia; now in remission

US News: NEW YORK: US Rep.

3 years ago·India

Read Full Article

Associated Press News

Rep. Zeldin was treated for leukemia and is now in remission

3 years ago·United States

Read Full Article

CNN

Rep. Lee Zeldin announces he was diagnosed with leukemia last fall and is in remission

Republican Rep. Lee Zeldin, who is running for governor of New York, said in a statement Saturday he was diagnosed with early-stage chronic myeloid leukemia last November, began treatment "with an immediately positive response and no side effects" and is now in remission.

3 years ago·Atlanta, United States

Read Full Article

CBS Local

Rep. Zeldin Was Treated For Leukemia And Is Now In Remission

NEW YORK (AP) — U.S. Rep. Lee Zeldin revealed Saturday that he was diagnosed last November with early stage chronic myeloid leukemia but said he responded well to treatments and is now in remission.Zeldin, a Long Island Republican who’s running for New York governor, said the diagnosis had no impact on his work or Army Reserve duties. The Iraq War veteran said he suffered no side effects from treatment and that his health is now “phenomenal.”“Ov…

3 years ago·United States

Read Full Article

The Washington Post

GOP Rep. Zeldin announces leukemia diagnosis, remission

Zeldin, a four-term congressman and vocal supporter of former president Donald Trump, is also running for governor of New York.

3 years ago

Read Full Article

The Hill

Zeldin says he's in remission after treatment for leukemia

New York Rep. Lee Zeldin (R) on Saturday announced that he was diagnosed with leukemia last year and that it is in remission following treatment.Zeldin's diagnosis had not been disclosed before this weekend, even a...

3 years ago·Washington, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.